Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

NiceRx review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Semaglutide: $149 every 4 weeks; $1,075 per 48-week plan; tirzepatide: $249 every 4 weeks; $1,749 per 48-week plan. Billing runs every four weeks; the lowest advertised equivalents require $1,075 or $1,749 for 48 weeks.

$99to start

then $149/4 wks ongoing

Flat price · every dose
Consult Medication Shipping
See plans at NiceRx
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

NiceRx at a glance

Semaglutide
$149 every 4 weeks; $1,075 per 48-week plan
Tirzepatide
$249 every 4 weeks; $1,749 per 48-week plan
Coverage
46 states — not available in Alaska, Mississippi, New Jersey, or Kansas
Brand-name
Compounded only

How we scored NiceRx

Every factor comes from NiceRx's own published pricing, disclosures and oversight, and the six combine into the 43/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance15/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit30/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs58/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost66/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support48/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness58/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Semaglutide: $149 every 4 weeks; $1,075 per 48-week plan; tirzepatide: $249 every 4 weeks; $1,749 per 48-week plan. Billing runs every four weeks; the lowest advertised equivalents require $1,075 or $1,749 for 48 weeks.

Before you sign up

What NiceRx's public site and signup page show before you hand over any details.

Worth knowing

  • The prices are printed on NiceRx's own pricing pages and are visible as soon as the page loads
  • Homepage and pricing pages state the ongoing per-month rate directly, ahead of any account creation
  • LegitScript verification badge is present and links to a live verification check
  • NiceRx LLC is a named legal entity based in Boca Raton, FL, per its own disclosures — most compounded-GLP-1 telehealth sites we've reviewed name no legal entity at all
  • The 4-state exclusion list (AK, MS, NJ, KS) is stated plainly rather than buried
  • We did not create an account or complete checkout — every fact here comes from the public site

Pricing

MedicationPricePlan
Compounded semaglutide$99 → $149Four-week recurring plan$149 every 4 weeks; $1,075 per 48-week plan. Billing runs every four weeks; the lowest advertised equivalents require $1,075 or $1,749 for 48 weeks.
Compounded tirzepatide$249Four-week recurring plan$249 every 4 weeks; $1,749 per 48-week plan. Billing runs every four weeks; the lowest advertised equivalents require $1,075 or $1,749 for 48 weeks.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what NiceRx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Semaglutide: $149 every 4 weeks; $1,075 per 48-week plan; tirzepatide: $249 every 4 weeks; $1,749 per 48-week plan.
  • LegitScript verification badge present and checkable, not just claimed
  • Named legal entity (NiceRx LLC) with a real city and state — most compounded telehealth sites disclose neither
  • Every batch stated as tested for sterility and potency
  • 46-state coverage, broader than many compounded-only competitors

The caveats

  • Billing runs every four weeks; the lowest advertised equivalents require $1,075 or $1,749 for 48 weeks.
  • No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
  • Not available in Alaska, Mississippi, New Jersey, or Kansas
  • Compounded only — no brand-name Wegovy/Zepbound option, no oral form
  • No named compounding pharmacy disclosed

The recurring charge arrives every four weeks

NiceRx’s current recurring offers are $149 every four weeks for semaglutide and $249 every four weeks for tirzepatide. Keep that unit attached to the amount when comparing programs. A 52-week year contains thirteen such cycles, so the charge is not equivalent to paying $149 or $249 twelve times a year.

The semaglutide material also carries a $99 introductory figure. That lower first payment should be separated from the continuing $149 four-week charge. Ask which promotion is available to the patient, what it covers and exactly when the next payment occurs. An introductory rate does not establish the renewal price merely because both appear on the same card.

The lowest equivalents involve a substantial upfront purchase

NiceRx also advertises $1,075 for a 48-week semaglutide plan and $1,749 for a 48-week tirzepatide plan. Those totals belong in a different comparison from the recurring four-week option. They cover a longer commitment and should not be presented as a small monthly payment that a reader can elect without buying the plan.

Forty-eight weeks is also shorter than a 52-week year. Confirm how the plan ends, whether another charge follows and how dispensing is scheduled across the paid period. Before choosing the longer route, ask what happens if the clinician changes the prescription or treatment stops. A lower equivalent figure does not by itself establish a refund for unused time.

Availability is more specific than a national headline

The service information supporting this review excludes Alaska, Mississippi, New Jersey and Kansas. Readers in those states should resolve access before proceeding, while readers elsewhere should still confirm the selected medication and pharmacy arrangement. A clinical service’s general footprint does not guarantee approval for a particular treatment.

NiceRx’s menu here is compounded medication, without an established brand Wegovy or Zepbound route or oral formulation in this offer. That matters to someone whose priority is a named approved product or avoiding injections. Do not assume that a broadly familiar telehealth brand provides every formulation merely because it participates in weight management.

Testing claims should connect to the actual pharmacy

NiceRx states that batches are tested for sterility and potency and displays a LegitScript badge. Those are seller disclosures to examine in context, rather than a reason to describe a compounded medication as FDA-approved. Certification of a business and the regulatory status of a particular finished medication are separate matters.

No compounding pharmacy is named publicly in its published information. Ask which pharmacy fills the prescription and what information accompanies the dispensed product. Knowing the pharmacy also clarifies whom to contact about shipment conditions, storage instructions or an issue with the medication itself, while clinical questions still belong with the treating professional.

A long plan should follow a clear care arrangement

Its public information does not describe a dedicated pregnancy, breastfeeding, postpartum or PCOS pathway. Someone seeking help for one of those circumstances needs a direct discussion with the actual prescriber, particularly before committing to a 48-week purchase. A long payment period is not evidence that the clinical plan will remain suitable throughout it.

NiceRx is most relevant to a reader who understands four-week billing and wants a choice between recurring payments and a longer prepaid plan. Its public amounts make that financial decision visible, but the lowest equivalent price should not dominate it. Confirm dose coverage, professional access, pharmacy identity and the current cancellation terms before choosing the commitment that best fits the care relationship.

The bottom line for mothers

Best for: Readers who can compare the full payment commitment and confirm the renewal amount before choosing a plan.

Alternatives to NiceRx

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • $165/mo semaglutide and $214/mo tirzepatide month to month, dropping to $97 and $177 on a 12-month plan — with a genuinely itemized exclusion list that explicitly screens out pregnancy, planned pregnancy, and breastfeeding rather than staying silent on it.

    Visit HealthRX
  • A complete plan table and real nationwide coverage, undercut by a homepage that strikes the same product through from two different “regular” prices.

    Visit bmiMD

Providers like NiceRx

Keep comparing NiceRx

NiceRx, answered

Is NiceRx's $99 price the real ongoing cost?
Semaglutide: $149 every 4 weeks; $1,075 per 48-week plan; tirzepatide: $249 every 4 weeks; $1,749 per 48-week plan. Billing runs every four weeks; the lowest advertised equivalents require $1,075 or $1,749 for 48 weeks.
Does NiceRx ship everywhere?
No — it excludes Alaska, Mississippi, New Jersey, and Kansas. Every other state plus DC is covered, which is broader than several compounded-only competitors we've reviewed.

Pricing, states and verification reflect NiceRx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers